BioSpace News Archive

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to September 2022.

AUM Biosciences Pte. Ltd. and Mountain Crest Acquisition Corp. V announced that they have entered into a definitive business combination agreement.

Biovica International Biovica, active in cancer diagnostics, announces that Anders Morén has been appointed as the company’s Chief Financial Officer.

University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world.

U.S. Patent No. 11,471,431 relates to the use of LP-300 to increase the survival time of patients with cancers overexpressing thioredoxin or glutaredoxin.

Tremeau Pharmaceuticals to Host Key Opinion Leader Webinar on Rofecoxib in Migraine Management on Tuesday, October 25th.

PharmaEssentia USA Corporation announced the recent appointment of three new female executives to the company’s U.S. leadership team.

BrainStorm Cell Therapeutics Inc. announced that a scientific abstract titled ‘NurOwn Phase 2 Clinical Trial in Progressive MS: Effects on CSF Neuroprotective Biomarkers’ will be presented at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, being held from October 26-28th in Amsterdam, NL.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Monday, November 7, 2022.

Immuneering Corporation announced the appointment of Leah R. Neufeld to the newly created position of Chief People Officer, effective immediately.